İçeriğe geç
akaturk Akademik ölçüm

Akademisyen

MEHMET ASIL

PROFESÖR

NECMETTİN ERBAKAN ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 119
  • Proje 0
  • Kitap 18
  • Bildiri 171
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 10 Q2 22 Q3 18 Q4 21
WoS (JCR) Q1 4 Q2 9 Q3 11 Q4 47
TR Index 40 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 1
Üst %10 makale 1
Ort. yüzdelik 52.6%
Üst %1 payı 7.7%
Üst %10 payı 7.7%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 119 yayın

Makale listesi

  1. 2026 Kronik Böbrek Yetmezliği Olan Hastalarda ERCP: Klinik Zorluklar ve Güncel Yaklaşımlar 119 Güncel Gastroenteroloji Dergisi YÖKSİS
  2. 2025 Bismuth-Based quintuple therapy: a step beyond quadruple regimens in H. Pylori treatment and the impact of patient compliance. BMC gastroenterology DOI 10.1186/s12876-025-04417-6 YÖKSİS SJR Q2 JCR Q2
  3. 2024 Acute cholestatic hepatitis due to infectious mononucleosis: A case report Turkish Journal of Internal Medicine DOI 10.46310/tjim.1303184 YÖKSİS
  4. 2024 Acute cholestatic hepatitis due to infectious mononucleosis: A case report Turkish Journal of Internal Medicine DOI 10.46310/tjim.1303184 YÖKSİS
  5. 2024 Hematolojik Malignitelerde Kemoterapi Ajanlarının Serum Elektrolit Düzeylerine Etkisi Mevlana Medical Sciences DOI 10.56752/Mevmedsci.2024.51 YÖKSİS
  6. 2023 Authors’ Reply to the Letter to the Editor: “Comprehensive Assessment of Inflammatory Indices to Predict Outcomes in Acute Pancreatitis” Journal of Investigative Surgery DOI 10.1080/08941939.2022.2161026 YÖKSİS SJR Q2 JCR Q2
  7. 2023 Authors’ Reply to the Letter to the Editor: “Comprehensive Assessment of Inflammatory Indices to Predict Outcomes in Acute Pancreatitis” J Invest Surg DOI 10.1080/08941939.2022.2161026 YÖKSİS SJR Q2 JCR Q2
  8. 2023 Authors’ Reply to the Letter to the Editor: “Comprehensive Assessment of Inflammatory Indices to Predict Outcomes in Acute Pancreatitis” Journal of Investigative Surgery DOI 10.1080/08941939.2022.2161026 YÖKSİS SJR Q2 JCR Q2
  9. 2023 An Etiological Evaluation of Children with Acute Recurrent Pancreatitis: Based on Genetic Analysis and Pancreaticobiliary Maljunction without Biliary Dilatation Chronicles of Precision Medical Researchers DOI 10.5281/zenodo.7718933 YÖKSİS
  10. 2023 Effect of the Using a Pupillometer on Recovery and Early Cognitive Functions in Anesthesia Management for Endoscopic Retrograde Cholangiopancreaticography in Geriatric Patients Journal of Surgery and Medicine DOI 10.28982/josam.7501 YÖKSİS
  11. 2023 AN ETİOLOGİCAL EVALUATİON OF CHİLDREN WİTH ACUTE RECURRENT PANCREATİTİS:BASED ON GENETİCS ANALYSİS AND PANCREATİCOBİLİARY MALJUNCTİON WİTHOUT BİLİARY DİLATATİON CHRONİCLES OF PRECİSİON MEDİCAL RESEARCHERS DOI 10.5281/zenodo.7718933 YÖKSİS OpenAlex 5.3%
  12. 2023 Assessment Of Serum Cyanocobalamin Level And Importance In Patients With Hematological Malignancies Turkish Journal of Clinics and Laboratory DOI 10.18663/tjcl.1225685 YÖKSİS TR Index
  13. 2023 Effect of the using a pupillometer on recovery and early cognitive functions in anesthesia management for endoscopic retrograde cholangiopancreaticography in geriatric patients Journal of Surgery and Medicine DOI 10.28982/josam.7501 YÖKSİS
  14. 2022 Hepatitis B Reactivation in Patients Treated with Direct-Acting Antivirals for Hepatitis C Digestive Diseases DOI 10.1159/000521298 YÖKSİS SJR Q2 JCR Q4
  15. 2022 Systemic Inflammation Response Index and Systemic Immune Inflammation Index Are Associated with Clinical Outcomes in Patients with Acute Pancreatitis? JOURNAL OF INVESTIGATIVE SURGERY DOI 10.1080/08941939.2022.2084187 YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %1 OpenAlex 99.0%
  16. 2022 Hepatitis B Reactivation in Patients Treated with Direct-Acting Antivirals for Hepatitis C S. Karger AG DOI 10.1159/000521298 YÖKSİS SJR Q2 JCR Q4
  17. 2022 Hepatitis B Reactivation in Patients Treated with Direct-Acting Antivirals for Hepatitis C. Digestive diseases (Basel, Switzerland) DOI 10.1159/000521298 YÖKSİS SJR Q2 JCR Q4
  18. 2022 Hepatitis B Reactivation in Patients Treated with Direct-Acting Antivirals for Hepatitis C DIGESTIVE DISEASES DOI 10.1159/000521298 YÖKSİS SJR Q2 JCR Q4
  19. 2022 Hepatitis B Reactivation in Patients Treated with Direct-Acting Antivirals for Hepatitis C Digestive Diseases DOI 10.1159/000521298 YÖKSİS SJR Q2 JCR Q4
  20. 2022 Hepatitis B Reactivation in Patients Treated with Direct-Acting Antivirals for Hepatitis C S. Karger AG DOI 10.1159/000521298 YÖKSİS SJR Q2 JCR Q4

Akademisyenlere dön